New patent for Novartis drug TASIGNA

Annual Drug Patent Expirations for TASIGNA Tasigna is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents protecting…

The post New patent for Novartis drug TASIGNA appeared first on DrugPatentWatch.

The post New patent for Novartis drug TASIGNA appeared first on Biotechblog.


This post was originally published on this site
Comments are closed.